InsidersTradesSigma
Follow the ニプロ株式会社 share price and the full management transaction log of the company, a listed equity based in Japan. Shares trade on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, ニプロ株式会社 has recorded 31 reports. Market capitalisation: €257.8bn. The latest transaction was reported on 7 July 2026 (Holding update). Among the most active insiders: Nomura Securities Co.,Ltd.. The full history is accessible without an account.
31
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ニプロ株式会社 Buy (bullish), based on 5 analysts. Average price target: JP¥1,986.
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,668 of 28,548 companies
54.9
score / 100
Value75
Quality35
FCF yld21%
Earn yld5.2%
EV/EBITDA8.8x
ROE5.2%
Gross mgn32%
Net mgn2.0%
Debt/EBITDA6.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2026
Declarations31 total
ShareXTKSEDINET:S100YPAN
ShareXTKSEDINET:S100YG70
ShareXTKSEDINET:S100Y8I4
ShareXTKSEDINET:S100Y5PA
ShareXTKSEDINET:S100Y5N5
ShareXTKSEDINET:S100XZWG
ShareXTKSEDINET:S100XWXE
ShareXTKSEDINET:S100XPAA
8.6% of flowShareXTKSEDINET:S100XPBS
ShareXTKSEDINET:S100XEEQ
ShareXTKSEDINET:S100WW6Q
ShareXTKSEDINET:S100WQ8K
ShareXTKSEDINET:S100WNEE
12.7% of flowShareXTKSEDINET:S100W2NL
ShareXTKSEDINET:S100VW4A
12.7% of flowShareXTKSEDINET:S100VVWZ
ShareXTKSEDINET:S100VG4B
14.3% of flowShareXTKSEDINET:S100VC5H
ShareXTKSEDINET:S100V781
ShareXTKSEDINET:S100UWPC
ShareXTKSEDINET:S100UTIL
ShareXTKSEDINET:S100UHO4
100.0% of flowShareXTKSEDINET:S100UH9E
ShareXTKSEDINET:S100U2T3
ShareXTKSEDINET:S100TARV
25 of 31 declarations
Acerca de ニプロ株式会社
Nipro Corporation es una empresa japonesa especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XTKS.